But these are anecdotal observations, not clinical evidence, and they shouldnt be taken as a basis for changing treatment without medical guidance. Alcohol and other substance use disorders are common, but they remain substantially underdiagnosed and undertreated
In practice, this changes nothing for patients: A licensed clinician still cannot prescribe these peptides through a legitimate compounding pharmacy until the FDA officially approves them
W., Chen, M., Chang, C
Since dulaglutide decreases monoaminergic neurotransmission in the amygdala in males but in the striatum in females (Vallof et al., 2020), the possibility that different mechanisms of action contribute to the decline in alcohol drinking in males and females should be considered
BPC-157 and UK Regulation UK classification depends on what a substance is, how it is presented, the claims surrounding it and its apparent intended use
V.KirakossianD.DawsonD.DryS